| Financial Year |
March 31 2023 |
| Monetary Funds |
1,569,088,012.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
20,000,000.00 |
| Accounts Receivable |
48,915,789.04 |
| Advances to Suppliers |
85,070,755.90 |
| Other Receivables |
35,641,626.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
9,062,742.33 |
| Dividend Receivable |
-- |
| Inventories |
3,524,778,277.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
272,838,788.89 |
| Total Current Assets |
5,556,333,249.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
15,425,376.88 |
| Investment Properties |
12,476,299.41 |
| Fixed Assetes |
5,840,914,133.15 |
| Under-construction Projects |
434,247,581.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
406,360,893.00 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
47,900,768.37 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
24,772,485.26 |
| Deferred Income Tax Assets |
998,720,922.41 |
| Other Non-Current Assets |
68,189,213.76 |
| Sub-Total of Non-Current Assets |
8,103,227,469.24 |
| Total Assets |
13,659,560,718.72 |
| Short-Term Loans |
297,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
691,159,645.61 |
| Accounts Received In Advance |
864,865.09 |
| Employee Compensation Payable |
73,272,649.14 |
| Taxes Payable |
687,561,396.79 |
| Interest Payable |
27,093,600.18 |
| Dividend Payable |
6,136,861.04 |
| Other payables |
3,751,822,764.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
295,589,756.02 |
| Other Current Liabilities |
236,367,693.20 |
| Sub-Total of Current Liabilities |
8,130,255,891.95 |
| Long-term Loans |
1,509,970,111.62 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
55,565,389.64 |
| Other Non-Current Liabilities |
4,100,000.00 |
| Sub-Total of Non-Current Liabilities |
1,643,883,684.62 |
| Total Liabilities |
9,774,139,576.57 |
| Paid-In Capital(Or Share Stock) |
523,239,250.00 |
| Capital Surplus |
42,165,327.20 |
| Surplus Reserve |
261,619,625.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,024,325,852.99 |
| Minority Stockholder's Interest |
42,121,922.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,843,299,219.54 |
| Owner's Equity（Stockholder's Equity） |
3,885,421,142.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,659,560,718.72 |
